Vnitr Lek 2006, 52(5):451-453
Metabolic PPAR receptors and skin
- III. interní klinika 1. lékařské fakulty UK a VFN, Praha, přednosta prof. MUDr. Štěpán Svačina, DrSc., MBA
Activators of metabolic PPAR receptors are used in diabetology and lipidology. Many substance influancing PPAR (β/δ) are in research. These substances will be perhaps used in obesitology and in atherosclerosis treatment. Much quicker is approaching the use in dermatology. The effect of receptor stimulation will be used in wound healing and in the treatment of allergic and proliferative diseases. Some realeted substancies influencing heterodimers with RXR or RAR receptors are used in the treatment of acne and skin lymfomas. Dermatology will be after internal medicine the second field where influencing of PPAR receptors will be very important.
Keywords: PPAR β (δ); dermatology; wound healin; acne; skin allergy
Received: August 19, 2005; Accepted: August 19, 2005; Published: May 1, 2006 Show citation
References
- Compe E, Egly JM. The DNA rapid/transcription factor TFIIH controls the transactivation by the peroxisome proliferator-activated receptors. Proceedings of 2nd International symposium on PPARs. Florencie: Fondazionne Giovanni Lorenzini 2003: 12.
- Di-Poi N, Michalik L, Tan NS et al. The anti-apoptotic role of PPAR β contributes to efficient skin wound healing. J Steroid Biochem Mol Biol 2003; 85: 257-265.
Go to original source...
Go to PubMed...
- Haluzík M, Svačina Š. Metabolický syndrom a jaderné receptory PPAR. Praha: Grada Publishing 2005.
- Kuenzli S, Saurat JH. Peroxisome proliferator-activated receptors in cutaneous biology. Br J Dermatol 2003; 149: 229-236.
Go to original source...
Go to PubMed...
- Pershadingh HA et al. Novel PPSR γ ligands for topical treatment of inflamamatory and proliferative diseases of skin. Proceedings of 2nd International symposium on PPARs. Florencie: Fondazionne Giovanni Lorenzini 2003: 11.
- Ruhl R et al. Inhibition of IGE production by PPAR ligands. Proceedings of 2nd International symposium on PPARs. Florencie: Fondazionne Giovanni Lorenzini 2003: 45.
- Shulman AI, Mangelsdorf DJ Retinoid X Receptor Heterodimers in the Metabolic syndrome. N Engl J Med 2005; 353: 604-615.
Go to original source...
Go to PubMed...
- Smuth M et al. Differentiation and lipid accumulation in PPAR γ treated keratinocytes. Proceedings of 2nd International symposium on PPARs. Florencie: Fondazionne Giovanni Lorenzini 2003: 12.
- Tan NS et al. Peroxisome proliferator-activated receptor (PPAR)-β as a target for wound healing drugs: what is possible? Am J Clin Dermatol 2003; 4: 523-530.
Go to original source...
Go to PubMed...